Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026)
Embecta's (EMBC) quarterly Non-Current Deferred Tax Liability came in at $63.4 million in Q1 2026, up 8.38% year-on-year from $58.5 million in Q1 2025, and up 3.93% quarter-over-quarter from $61.0 million in Q4 2025.
Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Embecta has disclosed Non-Current Deferred Tax Liability across 6 years of filings, most recently posting $63.4 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $63.4 million, up 8.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.4 million (up 8.38% YoY), and the FY2025 annual result was $62.6 million, up 15.71% from the prior year.
- Non-Current Deferred Tax Liability came in at $63.4 million for Q1 2026 at Embecta, up from $61.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $63.5 million in Q2 2025 to a low of $31.4 million in Q1 2022.
- The 5-year median for Non-Current Deferred Tax Liability is $54.1 million (2024), against an average of $50.3 million.
- Across the five-year window, Non-Current Deferred Tax Liability soared 82.28% in 2023 and declined 22.81% in 2024, its largest moves.
- Embecta's Non-Current Deferred Tax Liability stood at $33.3 million in 2022, then surged by 82.28% to $60.7 million in 2023, then slipped by 8.4% to $55.6 million in 2024, then increased by 9.71% to $61.0 million in 2025, then rose by 3.93% to $63.4 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $63.4 million (Q1 2026), $61.0 million (Q4 2025), and $62.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.40 Mn |
| Mar 31, 2026 | 63.40 Mn |
| Dec 31, 2025 | 61.00 Mn |
| Dec 31, 2025 | 61.00 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 63.50 Mn |
| Jun 30, 2025 | 63.50 Mn |
| Mar 31, 2025 | 58.50 Mn |
| Mar 31, 2025 | 58.50 Mn |
| Dec 31, 2024 | 55.60 Mn |
| Dec 31, 2024 | 55.60 Mn |
| Sep 30, 2024 | 54.10 Mn |
| Sep 30, 2024 | 54.10 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 36.20 Mn |
| Mar 31, 2024 | 36.20 Mn |
| Dec 31, 2023 | 60.70 Mn |
| Dec 31, 2023 | 60.70 Mn |